Jens Lundgren

Jens Lundgren

Clinical Professor

Member of:

  • Internal medicine: infection medicine


  1. 2020
  2. Published

    Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan

    Sivapalan, P., Ulrik, Charlotte Suppli, Lappere, T. S., Eklöf, J. V., Shaker, Saher Burhan, Bødtger, U. C. S., Browatzki, A., Meyer, Christian, Weinreich, U. M., Laursen, C. B., Biering-Sørensen, Tor, Knop, Filip Krag, Lundgren, Jens & Jensen , Jens-Ulrik Stæhr , 2020, In: Trials. 21, 1, 867.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Remdesivir til behandling af COVID-19-pneumoni

    Benfield, Thomas, Jensen, T. Ø., Johansen, I. S., Nielsen, H., Wiese, L., Østergaard, L. & Lundgren, Jens, 2020, In: Ugeskrift for Laeger. 182, 24, 3 p., V205031.

    Research output: Contribution to journalEditorialResearch

  4. Published

    The EuroSIDA study: 25 years of scientific achievements

    Laut, K., Kirk, O., Rockstroh, J., Phillips, A., Ledergerber, B., Gatell, J., Gazzard, B., Horban, A., Karpov, I., Losso, M., d’Arminio Monforte, A., Pedersen, C., Ristola, M., Reiss, P., Scherrer, A. U., de Wit, S., Aho, I., Rasmussen, L. D., Svedhem, V., Wandeler, G. & 14 others, Pradier, C., Chkhartishvili, N., Matulionyte, R., Oprea, C., Kowalska, J. D., Begovac, J., Miró, J. M., Guaraldi, G., Paredes, R., Raben, D., Podlekareva, D., Peters, L., Lundgren, Jens & Mocroft, A., 2020, In: HIV Medicine. 21, 2, p. 71-83 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Tuberculosis among Patients Undergoing Solid Organ Transplantation or Dialysis in a Low-Endemic Country, 2004-2017

    Helleberg, M., Cho, D., Ekenberg, C., Sørensen, S., Rix, M., Gustafsson, Finn, Rasmussen, A., Perch, Michael, Andersen, P. H. S., Lundgren, Jens & Andersen, A. B., 2020, In: Tuberculosis research and treatment. 2020, 7 p., 7636975.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines

    Phillips, A. N., Bansi-Matharu, L., Venter, F., Havlir, D., Pozniak, A., Kuritzkes, D. R., Wensing, A., Lundgren, J. D., Pillay, D., Mellors, J., Cambiano, V., Jahn, A., Apollo, T., Mugurungi, O., Ripin, D., Da Silva, J., Raizes, E., Ford, N., Siberry, G. K., Gupta, R. K. & 5 others, Barnabas, R., Revill, P., Cohn, J., Calmy, A. & Bertagnolio, S., 2020, In: The Lancet HIV. 7, 3, p. e193-e200

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Variant in ERAP1 promoter region is associated with low expression in a patient with a Behçet-like MHC-I-opathy

    Dimopoulou, C., Lundgren, Jens, Sundal, J., Ullum, H., Aukrust, P., Nielsen, Finn Cilius & Marvig, R. L., 2020, In: Journal of Human Genetics. 65, 3, p. 325-335 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium

    Neesgaard, B., Mocroft, A., Zangerle, R., Wit, F., Lampe, F., Günthard, H. F., Necsoi, C., Law, M., Mussini, C., Castagna, A., Monforte, A. DA., Pradier, C., Chkhartisvilli, N., Reyes-Uruena, J., Vehreschild, J. J., Wasmuth, J-C., Sönnerborg, A., Stephan, C., Greenberg, L., Llibre, J. M. & 16 others, Volny-Anne, A., Peters, L., Pelchen-Matthews, A., Vannappagari, V., Gallant, J., Rieger, A., Youle, M., Braun, D., De Wit, S., Petoumenos, K., Borghi, V., Spagnuolo, V., Tsertsvadze, T., Lundgren, Jens, Ryom, L. & RESPOND Study Group, R. S. G., 2020, In: PLoS ONE. 15, 12, 19 p., e0243625.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 Next

ID: 13961